On Demand Webinars

Innovative Approaches to Database Study Design and Analysis: Opportunities and Challenges
January 31, 2013
Slides Recording
Healthcare Reform Post-Election Implications for Patient Access
December 05, 2012
Slides Recording
Mixed Methods, Rasch Modeling and Content Validity in the Development of Patient-reported Outcomes
December 04, 2012
Slides Recording
Exploratory Data Analysis: Getting More Out of Experimental and Observational Data
October 31, 2012
Slides Recording
Neurogenesis & Computerized Cognitive Testing
October 24, 2012
Slides Recording
Time and Motion Studies: What are they? Why are they useful? What are the challenges?
October 23, 2012
Slides Recording
Improving Signal Detection and Metrics for Study Management: Tandem Assessment Evaluation Methodology
October 09, 2012
Slides Recording
Establishing a Foundation of Evidence for Successful Market Access: Phase I through Post-approval
September 19, 2012
Slides Recording
Identifying Sites of Concern in Clinical Trials in Psychiatry and Neurology
September 18, 2012
Slides Recording
Clinical Trial Simulation: A Role for Facilitating Early Economic Analyses?
September 12, 2012
Slides Recording
Ensuring Data Quality in Alzheimer's Disease Clinical Trials
September 06, 2012
Slides Recording
What Does Drug Pooling Mean for Your Drug - and Your Trial?
August 08, 2012
Slides Recording
Clinical Data Challenges in Child Psychiatric Clinical Trials
July 25, 2012
Slides Recording
A Writer's Perspective on the Wrangling of Safety Documents – Coordination and Integration across Multiple Requirements
July 17, 2012
Slides Recording
Eliciting Patient-Centered Outcomes: Determining the Relative Strengths, Opportunities and Challenges of 6 Common Research Designs
June 21, 2012
Slides Recording
Get Over It: Embrace Payer Expectations by Introducing Them Early in Product Development
May 02, 2012
Slides Recording
China, Russia & Other International Hardware Projects: 3 Case Studies
April 03, 2012
Recording
Forecasting Market Size and Burden of Illness Using Individual-Level Simulations
December 13, 2011
Slides Recording
Assessing Cognitive Function in Clinical Trials
December 07, 2011
Slides Recording
Multi-Faceted Registries: Not Your Typical Safety or Pregnancy Exposure Registry
November 30, 2011
Slides Recording
Regulatory Considerations for Non-Interventional Studies - Europe
November 03, 2011
Slides Recording
Part 3, Pharmacovigilance Webinar Series - Closing the Gap between Safety Signaling and Confirmatory Studies
November 02, 2011
Slides
Part 2, Pharmacovigilance Webinar Series - Pharmacovigilance for Co-marketed Products: Identifying and Overcoming Potential obstacles
October 26, 2011
Slides
Part 1, Pharmacovigilance Webinars Series - Out with the Old, In with the New: Operational Implications for the New European Pharmacovigilance Legislation
October 19, 2011
Slides
Innovative Technologies to Improve Data Quality in CNS Clinical Trials
October 12, 2011
Slides Recording
Patient Reported Outcome (PRO) Assessments in Clinical Trials: Navigating the EMA and FDA Regulatory Framework
September 22, 2011
Slides Recording
Why Nursing Services Improve Patient Adherence and Compliance
July 21, 2011
Slides Recording
Multi-National Retrospective Chart Review Studies
July 19, 2011
Slides Recording
Biometrics: Improve Quality with Cross-Functional Collaboration
June 29, 2011
Slides Recording
Operational Management of Non Interventional Studies (NIS) – A Project Manager's Perspective
June 07, 2011
Slides Recording
The Importance of Cognitive Function Testing in Global Drug Development
May 11, 2011
Slides Recording
Improve the Grade of Your REMS Communications: Increase Patient and HCP Comprehension
May 04, 2011
Slides Recording
Observational Research: Not Just for Safety Anymore!
April 21, 2011
Slides Recording
De-Risk Your Initial IND to Avoid a Clinical Hold
April 21, 2011
Slides Recording
Connecting with Patients in a Post-Marketing Environment through Mobile Technologies and Social Media
February 17, 2011
Slides Recording
How Risk Evaluation and Mitigation Strategies (REMS), Reimbursement and Distribution Initiatives Intersect to Minimize Risk, Optimize Access and Support Product Commercialization
October 27, 2010
Slides
The Costs of Autism in the United States
July 16, 2010
Recording
Risk-benefit models for pharmaceuticals and predicting the net impact of harm reduction strategies: How modeling can aid in evaluating the risks and benefits of medical treatments
March 02, 2010
Slides
Patient-Reported Outcomes (PROs): Overview of the Final FDA Guidance Document
February 23, 2010
Slides